Health Care & Life Sciences » Biotechnology | Scancell Holdings PLC

Scancell Holdings PLC | Balance Sheet

Fiscal year is May-April. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,491.30
5,566.20
3,059.00
6,527.40
2,672.30
10,303.20
Total Accounts Receivable
319.40
439.30
752.80
537.20
810.70
793.70
Other Current Assets
49.80
78.60
44.50
23.60
39.90
48.20
Total Current Assets
1,860.50
6,084.10
3,856.30
7,088.20
3,523.00
11,145
Net Property, Plant & Equipment
131.70
115.60
86.50
64.60
93.10
76.90
Intangible Assets
3,415.10
3,415.10
3,415.10
3,415.10
3,415.10
3,415.10
Total Assets
5,407.30
9,614.90
7,357.90
10,567.90
7,031.20
14,637
Accounts Payable
176.10
232.20
369.80
-
-
Other Current Liabilities
139.00
305.40
234.10
575.70
531.90
Total Current Liabilities
315.10
537.60
603.90
575.70
531.90
Total Liabilities
315.10
537.60
603.90
575.70
531.90
Common Equity (Total)
5,092.10
9,077.30
6,754.00
9,992.30
6,499.30
Total Shareholders' Equity
5,092.10
9,077.30
6,754.00
9,992.30
6,499.30
Total Equity
5,092.10
9,077.30
6,754.00
9,992.30
6,499.30
Liabilities & Shareholders' Equity
5,407.30
9,614.90
7,357.90
10,567.90
7,031.20

About Scancell Holdings

View Profile
Address
John Eccles House
Oxford Oxfordshire OX4 4GP
United Kingdom
Employees -
Website http://scancell.co.uk
Updated 07/08/2019
Scancell Holdings Plc engages in the development of novel therapeutic vaccines for the treatment of cancer. It operates through ImmunoBody and Moditope technology platforms. The company was founded by Lindy Gillian Durrant in 1997 and is headquartered in Oxford, the United Kingdom.